EX-16.1 2 ea021427301ex16-1_raphael.htm LETTER FROM WEINSTEIN INTERNATIONAL CPA, ADDRESSED TO THE SECURITIES AND EXCHANGE COMMISSION, DATED SEPTEMBER 11, 2024

Exhibit 16.1

 

 

September 11, 2024

 

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549-7561

 

Dear Sirs/Madams:

 

We have read Item 4.01 of Raphael Pharmaceutical Inc.’s Form 8-K dated September 11, 2024, and are in agreement with the statements contained in Item 4.01.(a). We have no basis to agree or disagree with other statements of the registrant contained therein.

 

/s/ Weinstein International C.P.A. (PCAOB Register No. 6629)
   
Weinstein International C.P.A.  
Certified Public Accountants  

 

Tel Aviv, Israel  
September 11, 2024